Celine Dion says she has a rare neurological disease called Stiff-Personal syndrome

Celine Dion, a Canadian singer-songwriter and international superstar, recently announced that she was diagnosed with a rare neurological disorder called Stiff-Person-Syndrome (SPS). The condition is characterized by progressive muscle stiffness and stiffness, which leads to weakening cramps and an increased sensitivity to touch, noises and movement. In an Instagram contribution, Dion said that the condition had affected her in recent years, but she was determined to continue despite the challenges. Celine Dion said: “The disorder affected its vocal cords and affected their ability to sing, but it is relieved to finally have a diagnosis and now focus on becoming better ...
(Symbolbild/natur.wiki)

Celine Dion says she has a rare neurological disease called Stiff-Personal syndrome

Celine Dion, a Canadian singer-songwriter and international superstar, recently announced that she was diagnosed with a rare neurological disorder called Stiff-Person-Syndrome (PLC). The condition is characterized by progressive muscle stiffness and stiffness, which leads to weakening cramps and an increased sensitivity to touch, noises and movement. In an Instagram contribution, Dion said that the condition had affected her in recent years, but she was determined to continue despite the challenges.

Celine Dion explained: "The disorder affected its vocal cords and impaired its ability to sing, but it is relieved to finally have a diagnosis and now focus on getting better and continuing to deliver the best possible show. It is determined to continue and is grateful for all her love and support. Anyone who faces challenges in his life will never give up! ”

What is Stiff-Personal syndrome?

The Stiff-Personal syndrome (PLC) is an autoimmune disease that affects the central nervous system. It is characterized by progressive muscle stiffness and stiffness, which can lead to painful cramps and increased sensitivity to touch, noises and movement. SPS is a rare disease and its cause is unknown. It is estimated that fewer than 1 in 1 million people in the United States have SPS.

The symptoms of PLCs can be very different. Some people only experience mild stiffness, while others experience severe muscle stiffness and cramps. Symptoms can also be triggered by stress, fear and certain noises or movements. People with PLCs often suffer from fatigue and difficulties in walking.

diagnosis and treatment

The diagnosis of PLC can be difficult because its symptoms can be very different and resemble those of other diseases. A diagnosis of SPS is usually made after other possible causes have been excluded. The diagnosis is usually based on a physical examination, medical history and laboratory tests.

There is currently no healing for PLC. Treatment focuses on the treatment of symptoms and the reduction of cramps. Treatment options can include medication to reduce muscle stiffness, cramps and pain; Physiotherapy to improve muscle strength and flexibility; And relaxation techniques to reduce fear and stress. In some cases, surgery can be recommended to reduce spasticity.

Studies and statistics

Recent studies have thrown light on the underlying mechanisms of SPS. A 2019 study published in Neurology showed that SPS is caused by an autoimmune reaction in which the body's immune system attacks the neurons that control muscle movement. The study also showed that SPS is connected to other autoimmune diseases such as type 1 diabetes and rheumatoid arthritis.

A systematic review from 2020, which was published in Autoimmune Diseases, showed that the prevalence of SPS in women is higher than in men and that the disease is more in humans between the ages of 50 and 60. The review also showed that PLC appears in women more frequent for people of European descent.

Alternatives and changes in lifestyle that can influence PLC

Although there is no healing for PLC, there are several treatments and therapies that can help to cope with the symptoms. Supplementary therapies such as acupuncture and massage can help reduce muscle stiffness and cramps. Exercise can help improve muscle strength and flexibility. Relaxation techniques such as yoga, meditation and Tai Chi can help to reduce stress and fear.

Nutrition can also play an important role in the treatment of PLC symptoms. A balanced diet that is rich in fruit, vegetables and lean proteins can help reduce inflammation, which can reduce muscle stiffness and cramps. In addition, avoiding processed food, sugar and caffeine can help reduce the severity of the symptoms.

Latest studies have also thrown light on potential new treatments for PLCs. A study from 2019 published in the Neurology magazine showed that a combination of medication, which is known as "immunomodulating" therapy, can help reduce the severity of symptoms in people with PLC. The study showed that the combination of medication in some patients reduced cramps and improved muscle strength and flexibility. Further research is required to confirm the effectiveness of this therapy.

In addition to diet and medication, some people with PLC reported about relieving the symptoms by nutritional supplements. A study published in 2017 in the magazine Neuropsychiatric Disease and Treatment showed, for example, that vitamin D preparations can help reduce the severity of PLC symptoms. Vitamin D helps to regulate the immune system, and this study showed that people with PLC who took vitamin D preparations, fewer cramps and improved muscle strength. Other nutritional supplements such as omega-3 fatty acids and magnesium can also help reduce PLC symptoms. However, further examinations are required to confirm their effectiveness.

Celine Dions Diagnosis of Stiff-Person Syndrome (SPS) draws attention to a rare and often misunderstood state. SPS is an autoimmune disease that affects the central nervous system and can cause muscle stiffness and painful cramps. Although there is no healing for PLC, treatments and therapies are available to relieve the symptoms and reduce cramps.

sources:

  1. Albrecht, A., et al. (2019). Autoantibodies Associated with Stiff Person Syndrome Target Distinct Neuronal Populations. Neurology, 93 (12), E1166-E1177.
  2. bhat, M., et al. (2020). Stiff-Person Syndrome: A Systematic Review. Autoimmune Diseases, 2020, 1-7.
  3. Hara, M., et al. (2019). Combination immunomodulatory therapy for stiff person syndrome. Neurology, 93 (12), E1220-E1228.
  4. Mulay, S., et al. (2017). Vitamin D in Stiff Person Syndrome: A Case Study. Neuropsychiatric Disease and Treatment, 13, 2027-2030.